TOBAM’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-362,069
| Closed | -$3.78M | – | 396 |
|
|
2023
Q4 | $3.78M | Sell |
362,069
-23,827
| -6% | -$249K | 0.33% | 59 |
|
|
2023
Q3 | $3.94M | Buy |
385,896
+382,559
| +11,464% | +$3.9M | 0.32% | 60 |
|
|
2023
Q2 | $25K | Buy |
+3,337
| New | +$25K | ﹤0.01% | 358 |
|
|
2020
Q2 | – | Sell |
-102,004
| Closed | -$916K | – | 169 |
|
|
2020
Q1 | $916K | Buy |
+102,004
| New | +$916K | 0.07% | 103 |
|
|
2018
Q4 | – | Sell |
-127,176
| Closed | -$2.74M | – | 168 |
|
|
2018
Q3 | $2.74M | Sell |
127,176
-249,451
| -66% | -$5.37M | 0.12% | 110 |
|
|
2018
Q2 | $9.16M | Sell |
376,627
-123,881
| -25% | -$3.01M | 0.38% | 75 |
|
|
2018
Q1 | $8.55M | Sell |
500,508
-371,099
| -43% | -$6.34M | 0.35% | 80 |
|
|
2017
Q4 | $16.5M | Buy |
871,607
+348,762
| +67% | +$6.61M | 0.71% | 58 |
|
|
2017
Q3 | $9.2M | Buy |
522,845
+143,497
| +38% | +$2.53M | 0.35% | 75 |
|
|
2017
Q2 | $12.6M | Sell |
379,348
-245,966
| -39% | -$8.17M | 0.47% | 62 |
|
|
2017
Q1 | $20.1M | Buy |
625,314
+159,218
| +34% | +$5.11M | 0.77% | 48 |
|
|
2016
Q4 | $16.9M | Sell |
466,096
-78,726
| -14% | -$2.85M | 0.69% | 52 |
|
|
2016
Q3 | $25.1M | Sell |
544,822
-210,025
| -28% | -$9.66M | 0.9% | 45 |
|
|
2016
Q2 | $37.9M | Buy |
754,847
+174,101
| +30% | +$8.75M | 1.52% | 30 |
|
|
2016
Q1 | $31.1M | Buy |
580,746
+351,854
| +154% | +$18.8M | 1.22% | 32 |
|
|
2015
Q4 | $15M | Buy |
+228,892
| New | +$15M | 0.65% | 52 |
|